American Renal Associates Holdings, Inc (ARA): Price and Financial Metrics


American Renal Associates Holdings, Inc (ARA): $11.52

0.02 (+0.17%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

ARA Stock Summary

  • American Renal Associates Holdings Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than just 1.53% of US listed stocks.
  • Price to trailing twelve month operating cash flow for ARA is currently 2.28, higher than merely 9.24% of US stocks with positive operating cash flow.
  • ARA's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of just 1.51% of US stocks.
  • If you're looking for stocks that are quantitatively similar to American Renal Associates Holdings Inc, a group of peers worth examining would be CBB, WOW, DIN, MDCA, and WYND.
  • Visit ARA's SEC page to see the company's official filings. To visit the company's web site, go to www.americanrenal.com.

ARA Stock Price Chart Interactive Chart >

Price chart for ARA

ARA Price/Volume Stats

Current price $11.52 52-week high $11.98
Prev. close $11.50 52-week low $5.57
Day low $11.33 Volume 9,800
Day high $11.52 Avg. volume 106,940
50-day MA $11.45 Dividend yield N/A
200-day MA $8.46 Market Cap 397.94M

American Renal Associates Holdings, Inc (ARA) Company Bio


American Renal Associates provides outpatient dialysis services in the United States. The company focuses on joint venture relationships with nephrologists. It offers services to hospitals that include dialysis patient discharge coordination; and acute inpatient dialysis services, such as inpatient hemodialysis, inpatient peritoneal dialysis, C.V.V.H., C.R.R.T., and apheresis. The company was founded in 1999 and is based in Beverly, Massachusetts.


ARA Latest News Stream


Event/Time News Detail
Loading, please wait...

ARA Latest Social Stream


Loading social stream, please wait...

View Full ARA Social Stream

Latest ARA News From Around the Web

Below are the latest news stories about American Renal Associates Holdings Inc that investors may wish to consider to help them evaluate ARA as an investment opportunity.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Mergers – WTRE, ARA, RESI, NK

NEW YORK, Dec. 30, 2020 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Watford Holdings Ltd. (NASDAQ: WTRE) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Arch Capital Group Ltd. for $35.00 per share. If you are a Watford shareholder, click here to learn more about your rights and options.American Renal Associates Holdings, Inc. (NYSE: ARA) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Innovative Renal Care, LLC, an affiliate of Nautic Partners, LLC, for $11.50 per share in cash. If you are an American Renal shareholder, click here to learn more about your...

Yahoo | December 30, 2020

Moore Kuehn Encourages CBMG, CLCT, TNAV, and ARA Investors to Contact Law Firm

NEW YORK, Dec. 29, 2020 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders.   Moore Kuehn may ultimately seek increased consideration, additional disclosures, or other relief and benefits on behalf of the shareholders of these companies: * Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) A proxy was recently filed with the SEC regarding the acquisition of Cellular Biomedicine by a consortium led by the company’s CEO Bizuo Liu. Under the proposed transaction, shareholders of Cellular Biomedicine will receive $19.75 for every share owned.   The investigation concerns whether Cellular Biomedicine’s board of di...

Yahoo | December 29, 2020

SHAREHOLDER ALERT: Halper Sadeh LLP Investigates the Following Companies - PRGX, STND, NK, EIDX, ARA

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

Yahoo | December 29, 2020

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Companies - STND, EIDX, WTRE, ARA, CGIX

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

Yahoo | December 19, 2020

Lifshitz Law Firm, P.C. Announces Investigation of ARA, BBIO, EIDX, CIT, EMIS, FCNCA, FCNCB, EV, MS, NAV, STND, and WTRE

American Renal Associates Holdings, Inc. (NYSE: ARA)

Yahoo | December 18, 2020

Read More 'ARA' Stories Here

ARA Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year 83.73%
3-year -30.31%
5-year -51.70%
YTD 0.61%
2020 10.41%
2019 -9.98%
2018 -33.79%
2017 -18.23%
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8802 seconds.